CA
SGNT

Continental Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Continental Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,500
Closed -$307K – 153
2016
Q2 		$307K Hold
20,500
– – 0.09% 113
2016
Q1 		$249K Buy
+20,500
New +$287K 0.07% 124

Continental Advisors's SGNT Position: Q3 2016 in Review

Continental Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 20,500 shares — an estimated $307K sold.

Continental Advisors first reported a position in SGNT in Q1 2016 and held it in 2 quarters. The position peaked at $307K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Continental Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Continental Advisors sold 20,500 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $307K.
  • Continental Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2016 and held it in 2 quarters.
  • Continental Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $307K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Continental Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.